Related Experiment Video
Updated: Aug 7, 2026
06:55
Diagnosis of Neoplasia in Barrett’s Esophagus using Vital-dye Enhanced Fluorescence Imaging
Published on: May 11, 2014
The minimally abnormal Papanicolaou smear
1Medical College of Wisconsin, Milwaukee, USA.
American Family Physician
|March 1, 1996
Summary
The Bethesda system standardizes cervical cytology, classifying more Pap smears as minimally abnormal. New guidelines suggest a conservative approach for mild abnormalities, improving patient care and reducing clinician anxiety.
Area of Science:
- Gynecologic Pathology
- Cytopathology
- Cervical Cancer Screening
Background:
- The Bethesda System (TBS) standardized cervical cytology nomenclature.
- Previous systems lacked definitions for modern histopathologic concepts.
- TBS increased classifications of minimally abnormal Pap smears.
Purpose of the Study:
- To evaluate the impact of The Bethesda System on cervical cytology reporting.
- To discuss new guidelines for managing minimally abnormal Pap smears.
- To improve patient care and reduce clinician anxiety regarding Pap smear results.
Main Methods:
- Review of current literature and guidelines on cervical cytology.
- Analysis of the implications of The Bethesda System's classification.
- Discussion of management strategies for minimally abnormal Pap smears.
Main Results:
- The Bethesda System provides a standardized framework for cervical cytology.
- Minimally abnormal Pap smears, including atypical squamous cells of undetermined significance (ASCUS), low-grade squamous intraepithelial lesions (LSIL), and atypical glandular cells (AGS), are more frequently identified.
- New guidelines advocate for a conservative, expectant management approach for these mild abnormalities.
Conclusions:
- The Bethesda System has improved cervical cytology standardization.
- A conservative approach to minimally abnormal Pap smears is recommended.
- Understanding and appropriate management of Pap smear results are crucial for optimal patient care.
